Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis.

Ivet Etchegaray-MoralesClaudia Mendoza-PintoPamela Munguía-RealpozoJuan Carlos Solis-PoblanoSocorro Méndez-MartínezJorge Ayón-AguilarCarlos Abud-MendozaMario García-CarrascoRicard Cervera

Published in: Rheumatology (Oxford, England) (2024)

Although there was no increased risk of DM in patients with SLE compared with controls, HCQ users or adherents had a decreased risk, whereas glucocorticoid users had an increased risk.

Keyphrases

systemic lupus erythematosus
glycemic control
disease activity
type diabetes
adipose tissue
weight loss